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captures the essence of the Barcelona BioMed Conference on Gene
Translation: Fidelity and Quality Control, which was held at the
Institut d’Estudis Catalans in Barcelona on December 2–4, 2013.
This meeting was powered by the dramatic resurgence of interest
in tRNA biochemistry following the realization that tRNA is much
more than a simple adaptor of the genetic code.
This realization stems in part from the emergence of new
convergent technologies, such as deep sequencing, bioinformatics,
biological mass spectrometry and ‘omic science, as well as from the
growing body of evidence that connects translation biology to the
cell cycle, metabolism and disease. Research on translation has
long focused on the interactions between the basic players of
translation (tRNA, aminoacyl-tRNA synthetases, transcripts and
ribosomes), but these interactions were mainly studied in isolation
from the rest of the cell. However, tRNAs have now emerged as key
players in the many mechanisms of control that tightly couple pro-
tein synthesis to the main signaling pathways that modulate cell
biology and pathophysiology. Recent discoveries on the connec-
tions between tRNAs and signaling pathways and cell function
have highlighted the need to establish a ﬂuid dialogue among lab-
oratories that approach the problem from its many different
perspectives.
The Barcelona BioMed Conference recognized and consolidated
these emerging ideas and discoveries, the scientiﬁc substance of
which is reﬂected in the ﬁve mini-reviews of this ‘FOCUS ON tRNA’
series. A major focus was the growing area of tRNA mistranslation
(see also Moghal et al.), from the perspective of pathological errors
in protein sequences due to mischarging of tRNAs, to the concept
of ‘‘adaptive mistranslation’’ as a stress response and survivalmechanism for many organisms. Another emerging topic was the
role of anticodon modiﬁcations and their effects upon codon usage
patterns and codon-biased translation in cell stress responses and
pathophysiology (Gu et al.). A third area of interest was discoveries
of direct mechanistic links between human diseases, such as can-
cer and neurodegeneration, and facets of tRNA biology including
tRNA modiﬁcation and maturation (Torres et al.), tRNA cleavage
(Anderson and Ivanov) and aminoacyl-tRNA synthetases (Laporte
et al.).
While the meeting successfully accomplished the objective of
bringing together a diverse group of scientists to discuss the pres-
ent and the future of tRNA research, this ‘FOCUS ON tRNA’ series
reﬂects its scientiﬁc substance, as well as the excitement still res-
onating among those who attended the conference. As co-organiz-
ers of this meeting and editors of the ‘FOCUS ON tRNA’ feature, we
hope that you might share the excitement about these new devel-
opments in tRNA biology.
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